Skip to main navigation
Skip to search
Skip to main content
The Capital Region of Denmark's Research Portal Home
Help & FAQ
Dansk
English
Home
Hospitals/departments
Researchers
Research output
Activities
Prizes
Search by expertise, name or affiliation
Tofacitinib for Acute Severe Ulcerative Colitis: A Systematic Review
Casper Steenholdt
*
, Pernille Dige Ovesen,
Jørn Brynskov
,
Jakob Benedict Seidelin
*
Corresponding author for this work
Gastroenterology
16
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Tofacitinib for Acute Severe Ulcerative Colitis: A Systematic Review'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Acute Severe Ulcerative Colitis
100%
Tofacitinib
100%
Colectomy
71%
Free Survival
42%
Adverse Events
14%
Embase
14%
Cochrane Library
14%
Infliximab
14%
Safety Self-efficacy
14%
MEDLINE
14%
Disease Duration
14%
Infectious Complications
14%
Potential Treatments
14%
Pediatric Population
14%
Second-line Treatment
14%
Herpes Zoster
14%
Clinical Remission
14%
Cyclosporine
14%
Pooled Cohorts
14%
Ongoing Clinical Trials
14%
Infliximab Failure
14%
Systematic Searching
14%
Endoscopic Remission
14%
Refractory Patients
14%
Original Observations
14%
GETAID
14%
Steroid Failure
14%
Medicine and Dentistry
Ulcerative Colitis
100%
Systematic Review
100%
Tofacitinib
100%
Colectomy
71%
Infliximab
28%
Adverse Event
14%
Cohort Analysis
14%
Clinical Trial
14%
Case-Control Study
14%
Disease Duration
14%
Pediatrics
14%
Disseminated Herpes Zoster
14%
Cyclosporine
14%
Infectious Complication
14%
Pharmacology, Toxicology and Pharmaceutical Science
Ulcerative Colitis
100%
Tofacitinib
100%
Remission
28%
Infliximab
28%
Cohort Study
14%
Adverse Event
14%
Case-Control Study
14%
Clinical Trial
14%
Disease Duration
14%
Ciclosporin
14%
Infectious Complication
14%
Herpes Zoster
14%